ADPT logo

Adaptive Biotechnologies (ADPT) Cash From Investing

Annual CFI

$77.79 M
-$51.85 M-40.00%

December 1, 2024

Summary

Performance

1-Year Change

-40%

3-Year Change

-57.07%

5-Year Change

+116.15%

15-Year Change

+113.53%

ADPT Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.69%
ADPT annual cash flow from investing activities is higher than 92.69% of companies in Healthcare sector

High & Low

All-time High

$181.21 M
ADPT annual cash flow from investing activities is currently -57.07% below its historical high of $181.21 million

3-Year Low

$2.90 M
ADPT annual cash flow from investing activities is currently +2577.87% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
ADPT previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
ADPT next annual earnings announcement has not yet been scheduled

OtherADPTcash flowmetrics:

Annual CFF

$241.00 K
ADPT annual cash flow from financing activities is $241.00 thousand

Annual CFO

-$95.21 M
ADPT annual cash flow from operations is -$95.21 million

Annual FCF

-$98.88 M
ADPT annual free cash flow is -$98.88 million

Annual CAPEX

$3.66 M
ADPT annual capital expenditures is $3.66 million

Quarterly CFI

$22.12 M
+$16.83 M+318.37%

December 1, 2024

Summary

Performance

3-Month Change

+318.37%

1-Year Change

+318.37%

3-Year Change

+366.06%

5-Year Change

+366.06%

ADPT Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.46%
ADPT quarterly cash flow from investing activities is higher than 88.46% of companies in Healthcare sector

High & Low

All-time High

$177.49 M
ADPT quarterly cash flow from investing activities is currently -87.54% below its historical high of $177.49 million

3-Year Low

-$97.54 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ADPT previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 7, 2025
ADPT next earnings announcement is scheduled for May 7, 2025

OtherADPTcash flowmetrics:

Quarterly CFF

$127.00 K
ADPT quarterly cash flow from financing activities is $127.00 thousand

Quarterly CFO

-$12.49 M
ADPT quarterly cash flow from operations is -$12.49 million

Quarterly FCF

-$12.57 M
ADPT quarterly free cash flow is -$12.57 million

Quarterly CAPEX

$80.00 K
ADPT quarterly capital expenditures is $80.00 thousand

TTM CFI

$77.79 M
+$18.91 M+32.12%

December 1, 2024

Summary

Performance

3-Month Change

+32.12%

1-Year Change

+32.12%

3-Year Change

-11.98%

5-Year Change

-11.98%

ADPT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.43%
ADPT TTM cash flow from investing activities is higher than 92.43% of companies in Healthcare sector

High & Low

All-time High

$269.69 M
ADPT TTM cash flow from investing activities is currently -71.15% below its historical high of $269.69 million

3-Year Low

$2.90 M
ADPT TTM cash flow from investing activities is currently +2577.87% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ADPT previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

May 7, 2025
ADPT next earnings announcement is scheduled for May 7, 2025

OtherADPTcash flowmetrics:

TTM CFF

$241.00 K
ADPT TTM cash flow from financing activities is $241.00 thousand

TTM CFO

-$95.21 M
ADPT TTM cash flow from operations is -$95.21 million

TTM FCF

-$98.88 M
ADPT TTM free cash flow is -$98.88 million

TTM CAPEX

$3.66 M
ADPT TTM capital expenditures is $3.66 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ADPT Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-40.0%+318.4%+32.1%
3 y3 years-57.1%+366.1%-12.0%
5 y5 years+116.2%+366.1%-12.0%

ADPT Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-57.1%+2577.9%-67.1%+122.7%-57.1%+2577.9%
5 y5-year-57.1%+116.2%-87.5%+106.5%-71.2%+116.2%
alltimeall time-57.1%+116.2%-87.5%+106.5%-71.2%+115.5%

Adaptive Biotechnologies Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
$77.79 M(-40.0%)
$22.12 M(+318.4%)
$77.79 M(+32.1%)
Sep 2024
-
$5.29 M(-10.0%)
$58.88 M(-26.2%)
Jun 2024
-
$5.88 M(-86.8%)
$79.73 M(-28.3%)
Mar 2024
-
$44.51 M(+1287.9%)
$111.18 M(-14.2%)
Dec 2023
$129.65 M(+4362.9%)
$3.21 M(-87.7%)
$129.65 M(+348.7%)
Sep 2023
-
$26.14 M(-30.0%)
$28.90 M(-52.5%)
Jun 2023
-
$37.32 M(-40.7%)
$60.77 M(+115.5%)
Mar 2023
-
$62.98 M(-164.6%)
$28.20 M(+870.6%)
Dec 2022
$2.90 M(-98.4%)
-$97.54 M(-268.1%)
$2.90 M(-98.3%)
Sep 2022
-
$58.02 M(+1122.4%)
$167.66 M(+89.7%)
Jun 2022
-
$4.75 M(-87.4%)
$88.38 M(-29.3%)
Mar 2022
-
$37.69 M(-43.9%)
$125.08 M(-31.0%)
Dec 2021
$181.21 M
$67.21 M(-416.0%)
$181.21 M(-180.2%)
Sep 2021
-
-$21.27 M(-151.3%)
-$226.05 M(-25.2%)
DateAnnualQuarterlyTTM
Jun 2021
-
$41.45 M(-55.8%)
-$302.03 M(+82.0%)
Mar 2021
-
$93.82 M(-127.6%)
-$165.98 M(+41.8%)
Dec 2020
-$117.04 M(-75.7%)
-$340.05 M(+249.7%)
-$117.04 M(-143.4%)
Sep 2020
-
-$97.25 M(-154.8%)
$269.69 M(+154.2%)
Jun 2020
-
$177.49 M(+24.3%)
$106.08 M(-190.9%)
Mar 2020
-
$142.76 M(+205.8%)
-$116.76 M(-75.8%)
Dec 2019
-$481.70 M(<-9900.0%)
$46.68 M(-117.9%)
-$481.70 M(-3.8%)
Sep 2019
-
-$260.85 M(+475.2%)
-$500.75 M(+113.3%)
Jun 2019
-
-$45.35 M(-79.6%)
-$234.76 M(+27.1%)
Mar 2019
-
-$222.18 M(-904.1%)
-$184.75 M(<-9900.0%)
Dec 2018
$736.00 K(-98.0%)
$27.63 M(+438.3%)
$736.00 K(-102.7%)
Sep 2018
-
$5.13 M(+10.1%)
-$26.89 M(-16.0%)
Jun 2018
-
$4.66 M(-112.7%)
-$32.03 M(-12.7%)
Mar 2018
-
-$36.69 M
-$36.69 M
Dec 2017
$36.43 M
-
-

FAQ

  • What is Adaptive Biotechnologies annual cash flow from investing activities?
  • What is the all time high annual CFI for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies annual CFI year-on-year change?
  • What is Adaptive Biotechnologies quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies quarterly CFI year-on-year change?
  • What is Adaptive Biotechnologies TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies TTM CFI year-on-year change?

What is Adaptive Biotechnologies annual cash flow from investing activities?

The current annual CFI of ADPT is $77.79 M

What is the all time high annual CFI for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high annual cash flow from investing activities is $181.21 M

What is Adaptive Biotechnologies annual CFI year-on-year change?

Over the past year, ADPT annual cash flow from investing activities has changed by -$51.85 M (-40.00%)

What is Adaptive Biotechnologies quarterly cash flow from investing activities?

The current quarterly CFI of ADPT is $22.12 M

What is the all time high quarterly CFI for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high quarterly cash flow from investing activities is $177.49 M

What is Adaptive Biotechnologies quarterly CFI year-on-year change?

Over the past year, ADPT quarterly cash flow from investing activities has changed by +$16.83 M (+318.37%)

What is Adaptive Biotechnologies TTM cash flow from investing activities?

The current TTM CFI of ADPT is $77.79 M

What is the all time high TTM CFI for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high TTM cash flow from investing activities is $269.69 M

What is Adaptive Biotechnologies TTM CFI year-on-year change?

Over the past year, ADPT TTM cash flow from investing activities has changed by +$18.91 M (+32.12%)